Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Use of an investigational monoclonal antibody called bimagrumab added to semaglutide produced weight loss while preserving ...

These patient testimonials helped push metreleptin over the line into approval, and the drug was finally approved for routine use on the NHS in January 2021.

Learn about Acquired Lipodystrophy, its causes, symptoms, types (AGL, APL), and treatments, including metabolic management and cosmetic options. Read more ...

Type Type Guidance (1259) NICE advice (214) Quality standard (132) ...

Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis ES35 24 February 2021 24 February 2021 ...

1 Introduction Fourman et al. have recently published a clinically-oriented rapid action plan for the diagnosis and management of lipodystrophy syndromes (1). Lipodystrophy syndromes may be ...

Introduction: Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute ...